Airy-beam holographic sonogenetics for advancing neuromodulation precision and flexibility.
Authors: Hu Z, Yang Y, Yang L, Gong Y, Chukwu C, Ye D, Yue Y, Yuan J, Kravitz AV, Chen H
Advancing our understanding of brain function and developing treatments for neurological diseases hinge on the ability to modulate neuronal groups in specific brain areas without invasive techniques. Here, we introduce Airy-beam holographic sonogenetics (AhSonogenetics) as an implant-free, cell type-specific, spatially precise, and flexible neuromodulation approach in freely moving mice. AhSonogenetics utilizes wearable ultrasound devices manufactured using 3D-printed Airy-beam holographic metasurfaces. These devices are designed to manipulate neurons genetically engineered to express ultrasound-sensitive ion channels, enabling precise modulation of specific neuronal populations. By dynamically steering the focus of Airy beams through ultrasound frequency tuning, AhSonogenetics is capable of modulating neuronal populations within specific subregions of the striatum. One notable feature of AhSonogenetics is its ability to flexibly stimulate either the left or right striatum in a single mouse. This flexibility is achieved by simply switching the acoustic metasurface in the wearable ultrasound device, eliminating the need for multiple implants or interventions. AhSonogentocs also integrates seamlessly with in vivo calcium recording via fiber photometry, showcasing its compatibility with optical modalities without cross talk. Moreover, AhSonogenetics can generate double foci for bilateral stimulation and alleviate motor deficits in Parkinson's disease mice. This advancement is significant since many neurological disorders, including Parkinson's disease, involve dysfunction in multiple brain regions. By enabling precise and flexible cell type-specific neuromodulation without invasive procedures, AhSonogenetics provides a powerful tool for investigating intact neural circuits and offers promising interventions for neurological disorders.
Introduction
Purpose
Transcranial ultrasound stimulation
Study Objective
To develop and demonstrate Airy-beam holographic sonogenetics, a wearable, implant‑free ultrasound method that enables cell type–specific, spatially precise, and dynamically steerable neuromodulation in freely moving mice.
Animal model / Human subject
Mouse, C57BL/6NCrl (Mus musculus; strain not specified; age 6-9 weeks; sex female)
Disease model
Parkinson's disease
Targeted brain region(s)
Striatum
Target coordinates
AP: 0.0 mm, ML: 2.2 mm, DV: 3.0 mm (dorsal) or 4.1 mm (ventral)
Outcomes and Safety
Summary of Outcomes
AhSonogenetics (TRPV1-expressing neurons) enabled implant-free, cell type–specific neuromodulation with clear behavioral effects: dorsal striatum stimulation evoked contralateral rotational behavior, ventral striatum stimulation reduced locomotion (~37% decrease), unilateral left/right targeting produced side-specific rotations, and bilateral dual-focus stimulation ameliorated motor deficits in Parkinson’s mice (≈2.8× increase in locomotor velocity), with minimal heating (~1.4°C) and no histological damage.
Safety-related matter
Stimulation produced a modest temperature increase (~1.4 ± 0.1 °C) and safety was confirmed by immunohistochemical staining for neurons, astrocytes, and microglia at 1.5 h, 1 d, and 2 d post‑stimulation, with no reported adverse effects.
Brain Region
Ultrasound Parameters
Ultrasound instrument
Wearable ultrasound devices for Airy-beam holographic sonogenetics (AhSonogenetics) manufactured using 3D-printed Airy-beam holographic metasurfaces; manufacturer: None reported; transducer aperture/diameter: None
FUS Frequency
3.0 MHz, 3.6 MHz
FUS Pressure
0.85 Mpa (peak negative pressure)
FUS Mode
pulsed
Pulse duration
40 ms
Duration of a single FUS session
10 minutes
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency
single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search